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in 39.7%. OSA was classified as mild (OSA-M) in 30.4% and as moderate
to severe (OSA-S) in 69.6%. After a median follow-up of 75 months (IQR
71-79), patients with OSA-S showed a significantly higher incidence of
the composite endpoint (relative risk 3.29, 95% CI 1.07-10.10; p=0.038).
Kapplan-Meier survival curves are represented in Figure 1. Adherence to
CPAP was 42.9% and there was a numerically lower proportion of patients
with composite endpoint in the group of compliant patients (33.3% vs.
37.5%, p=NS). 
Conclusions OSA has a high prevalence in ACS patients. Its screening has
high diagnostic yield and allows to identify patients with clearly unfavorable
prognosis and a potentially treatable risk factor. CPAP notes a significant
number of noncompliant, but may improve prognosis, justifying further ran-
domized clinical studies.
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Obesity is an independent risk factor for coronary artery disease and
premature death. However, a number of studies have demonstrated that it
is inversely associated with short-term mortality in patients with acute cor-
onary artery disease. Most data suggesting this “obesity paradox” identify
obesity with body mass index (BMI), but weight was not previously con-
sidered while it could be an alternative measurement that may also prove
to be an accurate predictor of in-hospital mortality. The aim of this study
was to determine whether BMI and weight are related to in-hospital mor-
tality in patients admitted for an acute coronary syndrome (ACS). Data
was derived from the EURHOBOP cohort, a multicenter ACS hospital reg-
istry conducted between 2008 and 2010 in 7 European countries. ACS
patients with discharge diagnosis of myocardial infarction or unstable
angina were included. Socio-demographic characteristics, medical histo-
ries and acute episodes at entry or during hospitalization were recorded.
In-hospital mortality risk by BMI or weight categories were assessed using
multiple logistic regression. A total of 6298 patients were included. Mean
age was 65.3±12.7 years, 75% were men, 27% had diabetes and 63% had
hypertension. ST-elevation ACS was observed in 31% of patients. BMI
ranged from 13.4 to 64.5kg/m2; 46% were overweight (25≤BMI<30) and
24% obese (BMI≥30). Weight ranged from 36 to 190kg. Mortality rate
was 3.1% [95% CI:2.7%-3.5%]. Based on ROC curves, optimal cutoff
points to predict in-hospital survival were 26kg/m2 for BMI and 75kg for
weight. In univariate logistic regression, BMI≥26kg/m2 (OR=0.69; [95%
CI]:0.52-0.92) or weight≥75kg (OR=0.57;[95% CI]:0.43-0.76) had a sig-
nificant protective association with mortality. However, none of these
associations remained significant in multivariate analysis. In EURHOBOP,
higher BMI and weight in ACS patients were not associated with better
short term in-hospital mortality.
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Background High-degree atrioventricular block (HAVB) is a common
complication of ST-segment elevation myocardial infarction (STEMI). HAVB
in STEMI is historically considered as a marker of worse outcome but overall
data about HAVB in the contemporary era of mechanical reperfusion and
potent antiplatelet therapies are scarce.
Aim We aimed at analyzing incidence, clinical correlates and impact on in-
hospital outcomes of HAVB in a large prospective registry (ORBI) of modern
management of STEMI with a special focus on potential differences between
patients with HAVB on admission and those who developed HAVB during
hospitalization.
Methods All patients enrolled in ORBI between June 2006 and December
2013 were included in the present analysis and were divided into 3 groups:
patients without HAVB at any time, patients with HAVB on admission and
those who developed HAVB during hospitalization. 
Results 6662 patients (age: 62.0 [52.0-74.0]; male: 76.3%) were
included in the present analysis. HAVB was documented in 3.5% of
patients, present on admission in 63.7% of patients and occurring during
hospitalization in 36.3%. Patients with HAVB on admission or occurring
during the first 24h of hospitalization had higher in-hospital mortality rates
(18.1% and 28.6% respectively) than patients without (4.5%) or with
HAVB occurring beyond the first 24h of hospitalization (8.0%). However
by multivariable analysis, HAVB was not independently associated with
in-hospital mortality. 
Conclusion Patients with HAVB had a higher mortality rate than patients
without. However HAVB is not an independent predictor of in-hospital mortality. 
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